Do You Need Parathyroid Surgery? Who Should Get an Operation and When
Written by John P. Sabra, MD FACS
Updated May 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
Surgery is the only cure for primary hyperparathyroidism. But not every patient with the diagnosis needs to rush to the operating room immediately, and for a subset of patients, careful observation is a reasonable alternative. Understanding the guidelines for when surgery is clearly recommended, when observation is appropriate, and why the threshold has shifted over time is the foundation of an informed conversation with your physician.
Primary hyperparathyroidism is caused by an overactive parathyroid gland producing too much PTH. The only definitive treatment is surgical removal of the abnormal gland. Medical options exist to manage specific consequences of the disease (such as medications to protect bone density), but none of them treat the underlying cause, and none of them provide the same outcomes as surgery. If cure is the goal, surgery is the path.
Symptomatic Patients: Surgery Is Clearly Indicated
Patients with symptomatic primary hyperparathyroidism have a clear indication for surgical management. A patient is considered symptomatic if they have experienced any of the following:
- Kidney stones caused by the hyperparathyroidism (nephrolithiasis)
- Significant bone disease: osteoporosis on bone density testing, or fragility fractures
- Hypercalcemic crisis: severely elevated calcium causing acute illness
- Neuromuscular symptoms: significant weakness or fatigue directly attributable to hypercalcemia
For these patients, surgery is not a matter of debate. It is the treatment. Delaying it allows the disease to cause further harm that could have been prevented.
The Asymptomatic Patient: Surgery Is Recommended More Often Than Most Patients Realize
The majority of patients with primary hyperparathyroidism today are discovered incidentally on routine blood tests, before they develop obvious kidney stones or fractures. They may not feel dramatically unwell. They are classified as “asymptomatic,” despite the fact that many report fatigue, brain fog, poor sleep, and mood changes that may be directly related to their hyperparathyroidism.
For these patients, major international guidelines recommend surgery when any of the following criteria are met:
| Criterion | Why It Matters |
|---|---|
| Serum calcium more than 1.0 mg/dL above the upper limit of normal | Significantly elevated calcium indicates more active disease with higher risk of complications |
| Bone mineral density T-score below -2.5 at the spine, hip, or distal radius | Established osteoporosis from hyperparathyroidism — surgery stops further bone loss and allows recovery |
| Vertebral fractures on imaging | Fractures from hyperparathyroidism-related bone loss represent established end-organ damage |
| Kidney stones on imaging, even without symptoms | Silent stones still carry recurrence risk; surgery significantly reduces future stone formation |
| Reduced kidney function (creatinine clearance below 60 mL/min) | Indicates the kidneys are being damaged by chronic hypercalciuria |
| 24-hour urine calcium above 400 mg with high-risk biochemical stone profile | High urine calcium predicts kidney stone formation and renal damage over time |
| Nephrocalcinosis (calcium deposits in kidney tissue) on imaging | Silent but significant renal damage from chronic hypercalcemia |
| Age under 50 years | Younger patients have decades of disease ahead; the cumulative risk of complications is substantially higher with longer time horizons |
Patients who do not meet the above criteria may still wish to pursue surgical management. Those with significant neurocognitive symptoms, fatigue, brain fog, depression, may experience improvement after surgery, though the evidence for this specific benefit is less uniform than the evidence for bone and kidney outcomes. A patient who feels significantly unwell and has a confirmed diagnosis of primary hyperparathyroidism has a reasonable basis for wanting definitive treatment regardless of whether they meet the formal criteria above.
The guidelines above represent the minimum threshold for recommending surgery — not the only basis on which surgery can be offered. Surgery is an option for all patients with confirmed primary hyperparathyroidism, including those who do not meet the formal asymptomatic criteria, if they have had a thorough discussion of the risks, potential benefits, and alternatives with a surgeon experienced in parathyroid disease. Many experienced parathyroid surgeons recommend surgery more broadly, particularly in otherwise healthy patients, because the operation is safe, the cure rate is high, and the disease is progressive.
When Observation Is Appropriate
Patients with mild, asymptomatic primary hyperparathyroidism who do not meet any of the surgical criteria above may elect to undergo observation. A structured observation protocol includes:
- Calcium and PTH levels every 6 to 12 months
- Bone mineral density testing every 1 to 2 years at three sites (spine, hip, and distal radius)
- Renal imaging to screen for silent kidney stones
- Annual assessment of kidney function
Observation is not the same as ignoring the problem. It is a defined monitoring protocol with specific tripwires that trigger reconsideration of surgery.
Bone mineral density in patients under observation tends to remain stable in the short term. However, after 8 years of observation, reductions in bone density at the hip and distal radius have been documented in patients who did not have surgery. This underscores that observation is not a permanent solution for most patients, it is a time-limited strategy that requires periodic reassessment.
Medical Management: What Medications Can and Cannot Do
Several medications have been evaluated for patients with primary hyperparathyroidism who cannot or do not wish to have surgery:
- Bisphosphonates (e.g., alendronate), can improve bone density at some sites but do not lower calcium or PTH, and do not address the underlying cause
- Hormone replacement therapy: may offer some bone protection in post-menopausal women but carries its own risks and does not treat the disease
- Cinacalcet (a calcimimetic), reduces PTH production and lowers serum calcium, but does not cure the disease, does not consistently improve bone density, and requires indefinite ongoing use
Medical management is an option for patients who are not surgical candidates due to serious comorbidities or who decline surgery after informed discussion. It is not a substitute for surgery in patients who are otherwise healthy and good operative candidates.
The Bottom Line
Surgery is the only cure for primary hyperparathyroidism, and the guidelines for recommending it are broader than most patients expect. If you have confirmed primary hyperparathyroidism and meet any of the surgical criteria above, surgery is the standard of care. If you do not meet the criteria, you have a reasonable choice between a structured observation protocol and elective surgery, and a conversation with a high-volume parathyroid surgeon is the right starting point for that decision.
The question to bring to your appointment is not just “do I need surgery?” but “what would you recommend for a patient with my specific calcium level, PTH, bone density, kidney function, and symptoms, and why?”
References
- Wilhelm SM, et al. AAES Guidelines for the Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016.
- NIH NIDDK — Primary Hyperparathyroidism.
- American Association of Endocrine Surgeons — Patient Resources.
This article was written by John P. Sabra, MD FACS and is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances, laboratory values, comorbidities, and clinical judgment determine the appropriate management for every patient.
More from the Parathyroid Disease series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →